Serine
- Generic Name
- Serine
- Brand Names
- Hepatamine 8, Clinimix 2.75/5, Clinimix E 2.75/5, Clinisol 15, Premasol, Procalamine 3, Plenamine, Primene, Periolimel, Freamine III 10, Trophamine 10 %, Aminosyn II 7 %, Aminosyn-PF 7%, Prosol, Sulfite-free, Travasol 10, Olimel, Freamine 6.9
- Drug Type
- Small Molecule
- Chemical Formula
- C3H7NO3
- CAS Number
- 56-45-1
- Unique Ingredient Identifier
- 452VLY9402
- Background
A non-essential amino acid occurring in natural form as the L-isomer. It is synthesized from glycine or threonine. It is involved in the biosynthesis of purines; pyrimidines; and other amino acids.
- Indication
Used as a natural moisturizing agent in some cosmetics and skin care products.
- Associated Conditions
- Iron Deficiency Anemia (IDA), Iron Deficiency (ID)
- Associated Therapies
- Amino acid supplementation
Serp-1 for the Treatment of Acute Coronary Syndrome
Phase 2
Terminated
- Conditions
- Unstable AnginaCoronary AtherosclerosisCoronary Restenosis
- First Posted Date
- 2005-10-21
- Last Posted Date
- 2009-02-06
- Lead Sponsor
- Viron Therapeutics Inc
- Target Recruit Count
- 72
- Registration Number
- NCT00243308
- Locations
- 🇨🇦
University of Ottawa Heart Institute, Ottawa, Ontario, Canada
🇺🇸University of Florida, Gainesville, Florida, United States
🇺🇸Washington Hospital Center, Washington, District of Columbia, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath